Whitehouse Labs, AMRI Increase E&L Expertise

Whitehouse Labs has furthered its efforts to expand its Extractables and Leachables expertise. Within Albany Molecular Research, Inc. (AMRI), the company has doubled its scientific staff dedicated to Extractables / Leachables & Impurities this past year and plans for further growth in 2017.

Along with additional personnel, critical instrumentation has been added to the E&L group. Instruments have been identified to further develop novel solutions to meet E&L needs. AMRI has also assembled experts to help customers navigate the evolution of Extractables & Leachables expectations. These include material scientists, analytical chemists, biomedical engineers, toxicologists, and biocompatibility specialists.
 
Recently, many E/L and chemical characterization guidelines, as well as standards, have been revised to better address patient safety considerations in the pharma/biotech and medical device industries. These heightened requirements cover final fill, intermediate storage, and manufacturing systems.
 
Whitehouse Labs, a division of AMRI, offers analytical services providing support for manufacturing from analytical chemistry and material qualification to packaging optimization.